MYDECINE INNOVATIONS GROUP
Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders. They use a world-class technology and drug development infrastructure, and advances new treatment options in areas of significant unmet need. Founded in 2020, the company is based in Vancouver, British Columbia, Canada.
MYDECINE INNOVATIONS GROUP
Industry:
Biotechnology Life Science Therapeutics
Founded:
2013-09-27
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.mydecineinc.com
Total Employee:
11+
Status:
Active
Contact:
604-687-2038
Email Addresses:
[email protected]
Total Funding:
2.27 M USD
Technology used in webpage:
SPF Amazon Google Apps For Business GoDaddy DNS AWS Global Accelerator GoDaddy Email GoDaddy Premium DNS
Current Employees Featured
Stock Details
Company's stock symbol is CNSX:MYCOF
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-06-10 | NeuroPharm | NeuroPharm acquired by Mydecine Innovations Group | 6 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-07-24 | Mydecine Innovations Group Inc. Appoints Previous Red Bull Sports Marketing Director Jim Gunning as CMO |
Official Site Inspections
http://www.mydecineinc.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ... 